ATLANTA, GA - Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today that it has secured $13.1 million in a Series D financing.
(more…)

ATLANTA, GA - The U.S. Food and Drug Administration U.S. Food and Drug AdministrationLatest from The Business JournalsAlcon files patent infringement claim against Apotex‘Gray’ drug market preys on hospitals hereFen-phen deadline nearing, Dallas lawyer warnsFollow this company on Friday stamped its approval on Dendreon Corp. Dendreon Corp.Latest from The Business JournalsSeattle Genetics’ new drug price: 8K per patientHines marketing planned Perimeter office towerWhich Seattle-area stocks are down the most?Follow this company’s Atlanta cancer immunotherapy manufacturing facility.
(more…)

ATLANTA, GA - Morrisville, NC-based Furiex Pharmaceuticals Inc. says it has inked a loan agreement for $15 million to support research and development on three of its clinical stage compounds. The lenders are MidCap Financial MidCap FinancialLatest from The Business JournalsHawaii Medical Center files Chapter 11 bankruptcy — againCarepoint acquires ArTex infusion firmAtherotech acquired by Behrman CapitalFollow this company and Silcon Valley Bank.
(more…)

ATLANTA, GA _ BioDelivery Sciences International Inc.BioDelivery Sciences International Inc.Latest from The Business JournalsBDSI poised to file to market drugBDSI lines up M to finance drugFirm claims BDSI infringing on its methodFollow this company said that its drug Onsolis will soon be sold in Canada – a development that could generate up to $30 million in sales milestones for the Raleigh-NC-based company.
(more…)

ATLANTA, GA - Cempra PharmaceuticalsCempra PharmaceuticalsLatest from The Business JournalsBlue Cross CEO, Quintiles president focus on costs at Health Care UDurham’s Clinpharm clocks growth as dosage specialistVC partner Kent joins Cempra boardFollow this company has raised $5 million in debt and warrants, according to U.S. Securities and Exchange Commission filings.
(more…)

ATLANTA, GA - The town of Jupiter, FL on Wednesday approved a $300,000 loan guarantee for ESI Florida, a biotechnology investment company that plans to create 150 jobs.
(more…)

ATLANTA, GA - Durham, NC-based venture capital fund Hatteras Venture Partners intends to announce today that it has raised $74 million for its fourth investment fund, putting it well more than halfway toward its $125 million goal.
(more…)

ATLANTA, GA - GeoVax Labs Inc.GeoVax Labs Inc.Latest from The Business JournalsGeoVax records 1,000 Q2 lossAIDS Research Alliance to test GeoVax HIV vaccine GeoVax trims first-quarter lossFollow this company has landed a $3.6 million Integrated Preclinical/Clinical AIDS Vaccine Development grant.
(more…)

Atlanta, GA – August 16, 2011 – Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. (more…)

SHREVEPORT, La. –Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for smoking cessation and other addictions, announced today that it has closed on $4.5 million in a continuation of its Series A financing. Embera’s existing venture investors, Louisiana Ventures, L.P., Louisiana Fund I, and Themelios Ventures, as well as private investors, participated in the round. Proceeds from this financing, combined with development grant funding from the National Institute for Drug Abuse, will support clinical development of EMB-001 through a Phase 1 safety study, enabling Embera’s clinical development programs for both smoking cessation and cocaine dependence.

(more…)